Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Blood|October 26, 2016
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphomaZijun Y Xu-Monette, Ling Li, John C Byrd, et al.
Research Square|January 27, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphomaKen Young, Wen-Yu Shi, Zijun Xu-Monette, et al.
Blood|January 25, 2013
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyShimin Hu, Zijun Y Xu-Monette, Aarthi Balasubramanyam, et al.
Oncotarget|June 24, 2015
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?Chi Young Ok, Qing Ye, Ling Li, et al.
Neoplasia (New York, N.Y.)|May 8, 2018
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell LymphomaXiaoxiao Wang, Xin Cao, Ruifang Sun, et al.
Blood|March 2, 2013
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium ProgramShimin Hu, Zijun Y Xu-Monette, Alexander Tzankov, et al.
Blood|September 8, 2012
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program StudyZijun Y Xu-Monette, Lin Wu, Carlo Visco, et al.
Blood Cancer Journal|July 17, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphomaWenyu Shi, Zijun Y Xu-Monette, Youchao Jia, et al.
Haematologica|August 30, 2012
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program StudyCarlo Visco, Alexander Tzankov, Zijun Y Xu-Monette, et al.
Nature Immunology|December 27, 2011
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleenIrene Puga, Montserrat Cols, Carolina M Barra, et al.
Pageof 8